Your browser doesn't support javascript.
loading
Physician interpretation of genomic test results and treatment selection.
Brusco, Lauren L; Wathoo, Chetna; Mills Shaw, Kenna R; Holla, Vijaykumar R; Bailey, Ann M; Johnson, Amber M; Khotskaya, Yekaterina B; Litzenburger, Beate C; Sanchez, Nora S; Zeng, Jia; Bernstam, Elmer V; Eng, Cathy; Kee, Bryan K; Amaria, Rodabe N; Routbort, Mark J; Mills, Gordon B; Mendelsohn, John; Meric-Bernstam, Funda.
Afiliação
  • Brusco LL; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wathoo C; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mills Shaw KR; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Holla VR; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bailey AM; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Johnson AM; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khotskaya YB; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Litzenburger BC; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sanchez NS; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zeng J; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bernstam EV; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Eng C; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Kee BK; Division of General Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Amaria RN; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Routbort MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mills GB; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mendelsohn J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Meric-Bernstam F; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 124(5): 966-972, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29165790
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Predisposição Genética para Doença / Genômica / Sequenciamento de Nucleotídeos em Larga Escala / Mutação / Neoplasias Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Predisposição Genética para Doença / Genômica / Sequenciamento de Nucleotídeos em Larga Escala / Mutação / Neoplasias Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article